Document Detail


Viral response in stable patients switching to fosamprenavir/ritonavir monotherapy (the FONT Study).
MedLine Citation:
PMID:  21729229     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVE: The aim of the study was to evaluate the efficacy of fosamprenavir/ritonavir (FPV/r) monotherapy in plasma and reservoirs in virologically suppressed patients.
METHODS: A 48-week, prospective, single-arm pilot trial was carried out (trial registration: ISRCTN78584791). Patients receiving triple therapy [FPV/r plus two nucleoside reverse transcriptase inhibitors (NRTIs) for at least the previous month], with viral load (VL) <40 HIV-1 RNA copies/mL and no previous virological failure (VF) on protease inhibitors (PIs), were included in the trial and received FPV/r monotherapy (700/100 mg/12 h). VL and FPV/r levels [by liquid chromatography-tandem mass spectrometry (LC/MS/MS); limit of detection (LOD) 0.5 ng/mL] in cerebrospinal fluid (CSF) were determined at week 24. VF was defined as VL >40 copies/mL in three consecutive samples or >500 copies/mL in two samples.
RESULTS: Enrolment was prematurely stopped because of a high percentage of VF. Twenty patients (45% men; median age 43.5 years) were included in the trial. Nine patients (45%) presented therapeutic failure [seven (35%) had VF, and two discontinued therapy]. Resistance testing was available in five patients. One patient presented major PI mutations (54L, 32I and 47V) in addition to one minor mutation (13V), whereas two patients had minor PI mutations (10V+36I and 71T, respectively). The patient with major PI mutations switched from FPV/r to darunavir/r and VL was re-suppressed. In the other six patients with VF, VL was re-suppressed after the reintroduction of NRTIs. VL was <40 copies/mL in all CSF samples (n=10). Median amprenavir plasma levels were 2.5 μg/mL (range 0.7-8.6 μg/mL) at week 24 and 2.5 μg/mL (range 0.4-3.8 μg/mL) at VF. The CSF amprenavir concentration was 28.1 ng/mL (range 6.39-83.6 ng/mL), exceeding the reported 50% inhibitory concentration (IC(50) ) range for CSF in nine of 11 patients.
CONCLUSIONS: The high percentage of patients with VF in our study suggests that the use of FPV/r in a simplification monotherapy strategy should be discouraged. Adequate amprenavir levels and undetectable VL in CSF were documented in all samples evaluated.
Authors:
M Saumoy; Jm Tiraboschi; M Gutierrez; J Niubó; P Domingo; A Vila; D Podzamczer
Related Documents :
20706039 - Role of tc-99m pertechnetate for remnant scintigraphy post-thyroidectomy.
19118429 - Utility of endoscopy in patients with incidental gastrointestinal luminal wall thickeni...
4023239 - False lumens in type iii aortic dissections: progress ct study.
1462019 - Radiological evidence of progression of bronchiectasis.
1104139 - Role of 67gallium citrate scanning in the management of non-hodgkin's lymphoma.
22769979 - A haemoperitoneum does not indicate active bleeding in the peritoneum in 50% of hypoten...
12655909 - Clozapine treatment in patients with prior substance abuse.
19931899 - Fetuin-a gene polymorphism in patients with calcium oxalate stone disease.
22615829 - Comparing hla shared epitopes in french caucasian patients with scleroderma.
Publication Detail:
Type:  Journal Article     Date:  2011-01-19
Journal Detail:
Title:  HIV medicine     Volume:  12     ISSN:  1468-1293     ISO Abbreviation:  HIV Med.     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-07-06     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100897392     Medline TA:  HIV Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  438-41     Citation Subset:  IM    
Copyright Information:
© 2011 British HIV Association.
Affiliation:
Infectious Disease Service, Bellvitge University Hospital Internal Medicine Service, HIV Unit, Sant Pau Hospital and Autonomous University Microbiology Service, Bellvitge University Hospital, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Functional dissection of SiiE, a giant non-fimbrial adhesin of Salmonella enterica.
Next Document:  The effects of weight loss strategies on gastric emptying and appetite control.